Genoss
CompanySouth Korea
Genoss develops one asset, in human trials (GENOSS DCB in multi vessel coronary artery disease). Mostly device acting on TUBB; based in South Korea.
- 1
- Asset
- Furthest stage
- Human trials
- 1
- Trial
- 1
- Signal
Pipeline
1Paclitaxel-coated balloon delivers paclitaxel locally to inhibit vascular smooth muscle proliferation and reduce restenosis.
Human trials, Device, TUBB, multi vessel coronary artery disease, percutaneous coronary intervention
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms1
- Trials1
- Signals2
- Similar companies6